Echinocystic acid activates PPARγ to alleviate mannan-induced psoriasis and psoriatic arthritis in mice
Main Article Content
Keywords
Echinocystic acid, PPARγ, mannan-induced psoriasis, psoriatic arthritis
Abstract
Previous studies have shown that echinocystic acid (EA) can reduce arthritis and skin damage, but the role of EA in psoriatic arthritis is unclear. This study aims to prove the role of EA in psoriatic arthritis, which was induced by intraperitoneal injection of mannan in C57BL/6J mice. The mice were divided into a control group, mannan group, mannan + EA (low-dose) group, and mannan + EA (high-dose) group. Joint tissue damage was scored, and pathological changes in joint tissue and ear skin damage were examined by HE staining. Pathway enrichment of EA drug targets was performed through the target enrichment website, and the mRNA and protein expression levels of pathway-related proteins in joint tissues and ears were verified using the PCR and western blot. The results show that injection of mannan into mice resulted in joint inflammatory infiltration and tissue damage, hyperkeratosis, and acanthosis of the ear skin, while these symptoms were alleviated after high-dose EA treatment. Pathway enrichment analysis showed that the EA drug treatment target is concentrated on the PPAR pathway. The mRNA and protein results showed that the mRNA and protein expression levels of peroxisome proliferator-activated receptor γ (PPARγ) in the joint tissues and ears of mice with psoriatic arthritis decreased, and the expression of PPARγ was activated after high-dose EA treatment. In conclusion, EA increases PPARγ expression and reduces joint and skin damage in mice with psoriatic arthritis.
References
2 He D, Hu G, Zhou A, Liu Y, Huang B, Su Y, et al. Echinocystic acid inhibits inflammation and exerts neuroprotective effects in MPTP-induced Parkinson’s disease model mice. Front. Pharmacol. 2021;12:787771. 10.3389/fphar.2021.787771
3 Cheng YC, Zhang X, Lin SC, Li S, Chang YK, Chen HH, et al. Echinocystic acid ameliorates arthritis in SKG mice by suppressing Th17 cell differentiation and human rheumatoid arthritis fibroblast-like synoviocytes inflammation. J. Agric. Food Chem. 2022;70(51):16176–87. 10.1021/acs.jafc.2c05802
4 Kang YM, Kim HM, Lee M, An HJ. Effects of echinocystic acid on atopic dermatitis and allergic inflammation of the skin and lungs. Phytomedicine. 2022;104:154211. 10.1016/j.phymed.2022.154211
5 Di T, Zhai C, Zhao J, Wang Y, Chen Z, Li P. Taxifolin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like mouse model via regulating cytoplasmic phospholipase A2 and PPAR-γ pathway. Int. Immunopharmacol. 2021;99:107900. 10.1016/j.intimp.2021.107900
6 Lin W, Shen P, Huang Y, Han L, Ba X, Huang Y, et al. Wutou decoction attenuates the synovial inflammation of collagen-induced arthritis rats via regulating macrophage M1/M2 type polarization. J. Ethnopharmacol. 2023;301:115802. 10.1016/j.jep.2022.115802
7 Zhong J, Scholz T, Yau ACY, Guerard S, Hüffmeier U, Burkhardt H, et al. Mannan-induced Nos2 in macrophages enhances IL-17-driven psoriatic arthritis by innate lymphocytes. Sci. Adv. 2018;4(5):eaas9864. 10.1126/sciadv.aas9864
8 Li Y, Chen L, Zheng D, Liu JX, Liu C, Qi SH, et al. Echinocystic acid alleviated hypoxic-ischemic brain damage in neonatal mice by activating the PI3K/Akt/Nrf2 signaling pathway. Front. Pharmacol. 2023;14:1103265. 10.3389/fphar.2023.1103265
9 Xiao L, Li M, Xiao Y, Yu L, Li Y, Zhang Z, et al. Echinocystic acid prevents obesity and fatty liver via interacting with FABP1. PTR. 2023;37(8):3617–30. 10.1002/ptr.7839
10 Wu D, Li H, Wang L, Hu Y, Huang H, Li J, et al. Echinocystic acid inhibits sepsis-associated renal inflammation and apoptosis by targeting protein tyrosine phosphatase 1B. Int. Immunopharmacol. 2024;142(Pt B):113076. 10.1016/j.intimp.2024.113076
11 Yang JH, Li B, Wu Q, Lv JG, Nie HY. Echinocystic acid inhibits RANKL-induced osteoclastogenesis by regulating NF-κB and ERK signaling pathways. Biochem. Biophy. Res. Commun. 2016;477(4):673–7. 10.1016/j.bbrc.2016.06.118
12 Ma Z, Wang Y, Piao T, Liu J. Echinocystic acid Inhibits IL-1β-induced COX-2 and iNOS expression in human osteoarthritis chondrocytes. Inflammation. 2016;39(2):543–9. 10.1007/s10753-015-0278-y
13 Deng YT, Kang WB, Zhao JN, Liu G, Zhao MG. Osteoprotective effect of echinocystic acid, a triterpone component from eclipta prostrata, in ovariectomy-induced osteoporotic rats. PlOS One. 2015;10(8):e0136572. 10.1371/journal.pone.0136572
14 Hegazy RA, Abdel Hay RM, Shaker O, Sayed SS, Abdel Halim DA. Psoriasis and metabolic syndrome: Is peroxisome proliferator-activated receptor-γ part of the missing link? EJD. 2012;22(5):622–8. 10.1684/ejd.2012.1789
15 Chen Y, Song S, Wang Y, Zhu J, Li X. Potential mechanism of oral baicalin treating psoriasis via suppressing Wnt signaling pathway and inhibiting Th17/IL-17 axis by activating PPARγ. PTR. 2022;36(10):3969–87. 10.1002/ptr.7546
16 Ni S, Yi N, Yuan H, Li D, Chen X, Zhuang C. Angelica sinensis polysaccharide improves mitochondrial metabolism of osteoarthritis chondrocytes through PPARγ/SOD2/ROS pathways. PTR. 2023;37(11):5394–406. 10.1002/ptr.7979
17 Bongartz T, Coras B, Vogt T, Schölmerich J, Müller-Ladner U. Treatment of active psoriatic arthritis with the PPAR gamma ligand pioglitazone: An open-label pilot study. Rheumatology. 2005;44(1):126–9. 10.1093/rheumatology/keh423
